PE20151298A1 - Composiciones oticas utiles para el tratamiento de infecciones del oido interno y externo en mamiferos - Google Patents

Composiciones oticas utiles para el tratamiento de infecciones del oido interno y externo en mamiferos

Info

Publication number
PE20151298A1
PE20151298A1 PE2015001315A PE2015001315A PE20151298A1 PE 20151298 A1 PE20151298 A1 PE 20151298A1 PE 2015001315 A PE2015001315 A PE 2015001315A PE 2015001315 A PE2015001315 A PE 2015001315A PE 20151298 A1 PE20151298 A1 PE 20151298A1
Authority
PE
Peru
Prior art keywords
concentration
mammals
treatment
internal
external ear
Prior art date
Application number
PE2015001315A
Other languages
English (en)
Inventor
Joseph A Capriotti
Bo Liang
C Michael Samson
Jason Stein
Michael Weiser
Original Assignee
Foresight Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44834943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20151298(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Foresight Biotherapeutics Inc filed Critical Foresight Biotherapeutics Inc
Publication of PE20151298A1 publication Critical patent/PE20151298A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0046Ear
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONSISTE DE: A) YODOPOVIDONA (PVP-I) A CONCENTRACION DE 2.0% (w/w); B) DEXAMETASONA A CONCENTRACION DE 0.1% (w/w); C) DIHIDRATO DISODICO EDETATO A CONCENTRACION DE 0.01% (w/w); D) CLORURO DE SODIO A CONCENTRACION DE 0.35% (w/w); E) TILOXAPOL A CONCENTRACION DE 0.05% (w/w); F) SULFATO DE SODIO A CONCENTRACION DE 1.2% (w/w); G) HIDROXIETILCELULOSA A CONCENTRACION DE 0.25% (w/w); Y H) AGUA ESTERIL. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS AGUDAS Y CRONICAS, VIRALES Y FUNGICAS DEL OIDO INTERNO, MEDIO Y EXTERNO DE MAMIFEROS, INCLUYENDO SERES HUMANOS
PE2015001315A 2009-02-27 2010-02-24 Composiciones oticas utiles para el tratamiento de infecciones del oido interno y externo en mamiferos PE20151298A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/380,463 US20090263345A1 (en) 2008-01-28 2009-02-27 Otic compositions for the treatment of infections of the internal and external ear in mammals

Publications (1)

Publication Number Publication Date
PE20151298A1 true PE20151298A1 (es) 2015-10-10

Family

ID=44834943

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2015001315A PE20151298A1 (es) 2009-02-27 2010-02-24 Composiciones oticas utiles para el tratamiento de infecciones del oido interno y externo en mamiferos
PE2011001555A PE20120183A1 (es) 2009-02-27 2010-02-24 Composiciones oticas que comprenden yodopovidona en combinacion con un esteroide

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2011001555A PE20120183A1 (es) 2009-02-27 2010-02-24 Composiciones oticas que comprenden yodopovidona en combinacion con un esteroide

Country Status (15)

Country Link
US (3) US20090263345A1 (es)
EP (2) EP3673736A1 (es)
JP (3) JP5714512B2 (es)
KR (4) KR20180017213A (es)
CN (2) CN105362286A (es)
AU (3) AU2010218108B2 (es)
BR (1) BRPI1012230A2 (es)
CA (1) CA2753964C (es)
CL (1) CL2011002091A1 (es)
CO (1) CO6450663A2 (es)
EC (1) ECSP11011354A (es)
MX (1) MX2011008920A (es)
NZ (1) NZ594884A (es)
PE (2) PE20151298A1 (es)
WO (1) WO2010099212A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
AU2015252097A1 (en) * 2009-12-15 2015-11-19 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
AU2010339993A1 (en) * 2009-12-15 2012-07-26 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
US20170071979A1 (en) * 2011-05-11 2017-03-16 Veloce Biopharma, Llc Composition and method for treating otitis
EP3348272B1 (en) * 2011-05-11 2020-06-24 Veloce BioPharma LLC Composition for use in the treatment of paronychia
WO2012177251A1 (en) * 2011-06-22 2012-12-27 Adeda Therapeutics Company Limited Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases
TW202023575A (zh) * 2011-09-16 2020-07-01 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物
CN102429862B (zh) 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
CN102988424A (zh) * 2012-12-29 2013-03-27 潍坊富邦药业有限公司 一种加速动物伤口愈合、止痛生肌的喷雾剂及制备工艺
RU2675813C2 (ru) * 2013-02-15 2018-12-25 Сэндзю Фармацевтикал Ко., Лтд. Эмульсионная композиция дифлупредната, содержащая цинк
DE102014000132A1 (de) * 2014-01-13 2015-07-16 Marco Bergmann Verfahren und Vorrichtung zum Anordnen mehrerer Lebensmittel in wenigstens einem Unterteil einer Verpackung
MX2017009450A (es) 2015-01-20 2018-01-18 Veloce Biopharma Llc Composicion yodofora novedosa y metodos de uso.
EP3495930A1 (en) * 2015-04-24 2019-06-12 LG Innotek Co., Ltd. Touch window
JP6255134B1 (ja) * 2016-11-02 2017-12-27 ヴェローチェ・バイオファーマ・エルエルシー 耳炎の治療のための組成物および方法
WO2019046844A1 (en) * 2017-09-02 2019-03-07 Iview Therapeutics, Inc. PHARMACEUTICAL COMPOSITIONS FORMING IN SITU A GEL AND THEIR USES FOR SINUS DISEASES
JP2022151438A (ja) * 2021-03-26 2022-10-07 均 石井 外耳炎と中耳炎と内耳炎の治療薬。

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114319A (en) * 1997-05-14 2000-09-05 Senju Pharmaceutical Co., Ltd. Compositions containing difluprednate
EP1429780B1 (en) * 2001-09-21 2005-12-21 Alcon, Inc. Method of treating middle ear infections
JP2006510657A (ja) * 2002-12-06 2006-03-30 アライバ ファーマシューティカルズ,インコーポレイティド 中耳炎の処置のための方法および組成物
US20060057226A1 (en) * 2004-09-16 2006-03-16 Johnson John M Red ear drops
EP1858506A2 (en) * 2005-03-10 2007-11-28 3M Innovative Properties Company Methods of treating ear infections
US20060280809A1 (en) * 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
US20080167281A1 (en) * 2007-01-05 2008-07-10 Preston David M Combination Otic Formulation
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
WO2008137658A1 (en) * 2007-05-03 2008-11-13 Mayo Foundation For Medical Education And Research Otitis externa
PL2291081T3 (pl) * 2008-06-12 2021-01-25 Takeda Pharmaceutical Company Limited Jodopowidon, nowy alternatywny środek konserwujący do kompozycji okulistycznych

Also Published As

Publication number Publication date
EP2400842A1 (en) 2012-01-04
JP5714512B2 (ja) 2015-05-07
CL2011002091A1 (es) 2012-04-20
US20090263345A1 (en) 2009-10-22
KR20160112024A (ko) 2016-09-27
CA2753964C (en) 2019-03-12
KR20190100237A (ko) 2019-08-28
ECSP11011354A (es) 2011-12-30
WO2010099212A1 (en) 2010-09-02
MX2011008920A (es) 2011-09-09
US20120003174A1 (en) 2012-01-05
JP2017031202A (ja) 2017-02-09
EP2400842A4 (en) 2013-08-28
CA2753964A1 (en) 2010-09-02
EP3673736A1 (en) 2020-07-01
AU2016203574B2 (en) 2017-08-31
CO6450663A2 (es) 2012-05-31
KR20180017213A (ko) 2018-02-20
AU2010218108B2 (en) 2016-07-07
AU2016203574A1 (en) 2016-06-16
NZ594884A (en) 2014-02-28
AU2010218108A1 (en) 2011-10-20
AU2017268575A1 (en) 2017-12-14
PE20120183A1 (es) 2012-03-15
CN102333444A (zh) 2012-01-25
BRPI1012230A2 (pt) 2017-11-07
JP2015083589A (ja) 2015-04-30
KR20110133479A (ko) 2011-12-12
JP2012519175A (ja) 2012-08-23
CN105362286A (zh) 2016-03-02
US20130089510A1 (en) 2013-04-11

Similar Documents

Publication Publication Date Title
PE20151298A1 (es) Composiciones oticas utiles para el tratamiento de infecciones del oido interno y externo en mamiferos
AR084285A1 (es) Composiciones inmunogenicas
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
CL2008001301A1 (es) Compuestos derivados de heterociclos de nitrogeno; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una condicion inflamatoria o alergica, tal como una enfermedad inflamatoria u obstructiva de las vias respiratorias mediada por el bloqueo del canal de sodio epitelial.
ITMI20042189A1 (it) Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
AR080368A1 (es) Disoluciones acuosas transparentes de acetonido de fluocinolona para el tratamiento de la inflamacion de oido
NZ701559A (en) Compositions comprising povidone-iodine
BR112013032974A2 (pt) "derivados de 1,6-diazabiciclo [3,2,1]-octan-7-ona, seus usos, e composições farmacêuticas".
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
AR078161A1 (es) Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
ECSP077182A (es) Metodos para el tratamiento de infecciones endobronquiales
BR112012015967A2 (pt) uso de compostos de fórmula geral (i) e composição farmacêutica
CL2008002384A1 (es) Compuestos derivados de quinoliniloxipiperidina y pirrolidina, composicion farmaceutica, combinacion farmaceutica, util para el tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio.
BR112018068642A2 (pt) composição e uso de composição
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
AR056835A1 (es) Composicion que contiene oligosacaridos
EA201201457A1 (ru) Органические композиции для лечения заболеваний, связанных с бета-субъединицей эпителиальных натриевых каналов
RS53907B1 (en) USE OF NIFURATEL FOR TREATMENT OF ATOPOBIUM-CAUSED INFECTIONS
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
NO20075758L (no) Polymorfer av 3-0-(3',3'-dimetylsuccinyl) betulin syre di-N-metyl-D-glukamin
PE20130374A1 (es) Composicion farmaceutica que comprende ibuprofeno
PE20070529A1 (es) Composicion farmaceutica que contiene azodicarbonamida micronizada y su preparacion
PA8789101A1 (es) Composición farmacéutica estable que comprende una sal de vinflunina hidrosoluble
BR112015008964A2 (pt) composições injetáveis estáveis contendo diclofenaco e tiocolquicosídeo